Asset Details
Do you wish to reserve the book?
Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection
Do you wish to request the book?
Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Biallelic JAK1 mutations in immunodeficient patient with mycobacterial infection
2016
Overview
Mutations in genes encoding components of the immune system cause primary immunodeficiencies. Here, we study a patient with recurrent atypical mycobacterial infection and early-onset metastatic bladder carcinoma. Exome sequencing identified two homozygous missense germline mutations, P733L and P832S, in the JAK1 protein that mediates signalling from multiple cytokine receptors. Cells from this patient exhibit reduced JAK1 and STAT phosphorylation following cytokine stimulations, reduced induction of expression of interferon-regulated genes and dysregulated cytokine production; which are indicative of signalling defects in multiple immune response pathways including Interferon-γ production. Reconstitution experiments in the JAK1-deficient cells demonstrate that the impaired JAK1 function is mainly attributable to the effect of the P733L mutation. Further analyses of the mutant protein reveal a phosphorylation-independent role of JAK1 in signal transduction. These findings clarify JAK1 signalling mechanisms and demonstrate a critical function of JAK1 in protection against mycobacterial infection and possibly the immunological surveillance of cancer.
JAK1 mediates intracellular signalling from multiple cytokine receptors. Here, Eletto
et al
. identify JAK1 mutations that disrupt multiple signalling pathways and are associated with primary immunodeficiency, atypical mycobacterial infection susceptibility and early-onset metastatic bladder carcinoma.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ 38/22
/ 38/23
/ 38/77
/ 38/90
/ 692/4017
/ Alleles
/ Biopsy
/ Bones
/ Child
/ Female
/ Gene Expression Regulation - drug effects
/ Humanities and Social Sciences
/ Humans
/ Interferon-alpha - pharmacology
/ Interferon-gamma - pharmacology
/ Kinases
/ Male
/ Mutation
/ Mycobacterium Infections - enzymology
/ Mycobacterium Infections - genetics
/ Pedigree
/ Phosphorylation - drug effects
/ Proteins
/ Science
/ Signal Transduction - genetics
/ STAT Transcription Factors - metabolism
/ Vaccines
